Three Stocks That May Be Undervalued By The Market In December 2024

As global markets navigate a period of economic uncertainty, with the European Central Bank and Swiss National Bank cutting rates and the U.S. Federal Reserve expected to follow suit, investors are witnessing mixed performances across major indices. Amidst this backdrop, while growth stocks have recently outperformed value stocks, there remains potential for certain undervalued stocks to capture investor interest by offering promising fundamentals that may not yet be fully recognized by the market.

Top 10 Undervalued Stocks Based On Cash Flows

Name	Current Price	Fair Value (Est)	Discount (Est)
Strike CompanyLimited (TSE:6196)	¥3645.00	¥7281.65	49.9%
Sudarshan Chemical Industries (BSE:506655)	₹1129.35	₹2250.95	49.8%
Wuhan Keqian BiologyLtd (SHSE:688526)	CN¥14.62	CN¥29.09	49.7%
Lindab International (OM:LIAB)	SEK225.40	SEK450.75	50%
Decisive Dividend (TSXV:DE)	CA$5.93	CA$11.84	49.9%
GlobalData (AIM:DATA)	£1.875	£3.75	50%
Western Alliance Bancorporation (NYSE:WAL)	US$82.86	US$165.30	49.9%
HealthEquity (NasdaqGS:HQY)	US$94.76	US$189.22	49.9%
Charter Hall Group (ASX:CHC)	A$14.37	A$28.58	49.7%
Hanall Biopharma (KOSE:A009420)	₩32650.00	₩65043.15	49.8%

Click here to see the full list of 911 stocks from our Undervalued Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

Exail Technologies (ENXTPA:EXA)

Overview: Exail Technologies operates in the robotics, maritime, navigation, aerospace, and photonics sectors both in France and internationally, with a market cap of €290.25 million.

Operations: The company's revenue is primarily derived from its Navigation & Maritime Robotics segment, which accounts for €252.35 million, and its Advanced Technologies segment, contributing €87.52 million.

Estimated Discount To Fair Value: 15%

Exail Technologies, trading at €17.08, is undervalued based on its discounted cash flow analysis with a fair value estimate of €20.09. Despite a recent half-year net loss of €3.71 million against last year's net income, the company is forecast to achieve above-average market profit growth over the next three years and revenue growth of 14.8% annually, outpacing the French market's 5.6%. Analysts anticipate a price increase of 38.8%.

• The growth report we've compiled suggests that Exail Technologies' future prospects could be on the up.
• Get an in-depth perspective on Exail Technologies' balance sheet by reading our health report here.

Fujio Food Group (TSE:2752)

Overview: Fujio Food Group Inc. operates restaurants in Japan and internationally, with a market cap of ¥53.77 billion.

Operations: Fujio Food Group Inc. generates revenue primarily from its restaurant operations both domestically in Japan and abroad.

Estimated Discount To Fair Value: 33.1%

Fujio Food Group, currently priced at ¥1182, is trading 33.1% below its estimated fair value of ¥1767.19 based on discounted cash flow analysis. Despite expected slower revenue growth of 6.5% annually compared to the market's 4.2%, the company's earnings are forecast to grow significantly by 80.52% per year and become profitable within three years, indicating strong potential for future financial performance amidst a recent follow-on equity offering of ¥6.06 billion.

• Our expertly prepared growth report on Fujio Food Group implies its future financial outlook may be stronger than recent results.
• Navigate through the intricacies of Fujio Food Group with our comprehensive financial health report here.

Stemmer Imaging (XTRA:S9I)

Overview: Stemmer Imaging AG offers machine vision technology for a variety of industrial and non-industrial applications globally, with a market capitalization of €351 million.

Operations: The company generates its revenue from the machine vision technology segment, amounting to €113.27 million.

Estimated Discount To Fair Value: 14.0%

Stemmer Imaging is trading at €54, below its estimated fair value of €62.77, suggesting potential undervaluation based on cash flows. Despite a recent decline in sales and profits, the company's earnings are forecast to grow significantly at 37.2% annually over the next three years, outpacing the German market's growth rate. The recent takeover by MiddleGround Management may offer stability and strategic direction but has led to an unstable dividend track record.

• Upon reviewing our latest growth report, Stemmer Imaging's projected financial performance appears quite optimistic.
• Unlock comprehensive insights into our analysis of Stemmer Imaging stock in this financial health report.

Where To Now?

• Navigate through the entire inventory of 911 Undervalued Stocks Based On Cash Flows here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com